1. Açık Erişim@BUU

Browsing by Author Farci, Patrizia

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)
2009-10A finite course of peginterferon alfa-2a results in inactive chronic hepatitis b and hbsag clearance 5 years post-treatment in patients with hbeag-negative disease: Baseline characteristics and predictive factors of long-term responseMarcellin, Patrick; Piratvisuth, Teerha; Brunetto, Maurizia; Bonino, Ferruccio; Farci, Patrizia; Yurdaydın, Cihan; Kapprell, Hans Peter; Messinger, Diethelm; Batrla, Richard; Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Gastroenteroloji Bilim Dalı.; Gürel, Selim
2009Increasing rates of hbsag clearance and seroconversion in patients with hbeag-negative disease treated with peginterferon alfa-2a +/- lamivudine: Results of 5-year post-treatment follow upMarcellin, Patrick; Piratvisuth, Teerha; Brunetto, Maurizia; Bonino, F.; Lau, George; Farci, Patrizia; Yurdaydın, Cihan; Wu, J.; Popescu, Matei; Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Gastroenteroloji Bilim Dalı.; Gürel, Selim
2006The majority of patients with HBeAg-negative chronic hepatitis B treated with peginterferon alpha-2a (40KD) [PEGASYS (R)] sustain responses 2 years post-treatmentMarcellin, Patrick; Bonino, Ferruccio; Lau, George; Farci, Patrizia; Yurdaydin, C.; Piratvisuth, Teerha; Jin, R.; Hadziyannis, Stephanos J.; Lu, Zhimeng; Popescu, Madalina; Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı/Gastroenteroloji Bilim Dalı.; Gürel, Selim
2005-04On-treatment predictors of sustained biochemical and virological response in patients with HBeAg-negative chronic hepatitis B (CHB) treated with peginterferon alpha-2a (40 kDa) (Pegasys (R))Farci, Patrizia; Marcellin, Patrick; Lu, Zhi-Meng; Diago, Moises; Lai, Ming-Yang; Kittis, G; Yurdaydin, Cihan; Zahm, FE; Bonino, FD; Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı.; Gürel, Selim
2004-09-16Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis BMarcellin, Patrick; Lau, George; Bonino, Ferruccio; Farci, Patrizia; Hadziyannis, Stephanos; Jin, R.; Lu, ZM; Piratvisuth, Teerha; Germanidis, Georgios; Yurtaydin, Cihan; Moises, Diago; Mingyang, Lai; Button, P.; Pluck, Nigel; Bursa Uludağ Üniversitesi/Tıp Fakültesi.; Gurel, Selim
2006-10Suppression of HBV DNA in patients with HBeAg-negative CHB treated with peginterferon alfa-2A (40KD) +/- lamivudine: 2-year follow-up resultsMarcellin, Patrick; Bonino, Ferruccio; Lau, George; Farci, Patrizia; Yurdaydin, Cihan; Piratvisuth, Teerha; Luo, Kangxian; Hadziyannis, Stephanos J.; Wang, Yuming; Popescu, Matei; Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı.; Gürel, Selim
2009-06Sustained response of Hepatitis B e Antigen-Negative patients 3 years after treatment with Peginterferon Alfa-2aYurdaydın, Cihan; Marcellin, Patrick; Bonino, Ferruccio; Lau, George; Farci, Patrizia; Piratvisuth, Teerha; Jin, Rui; Lu, Zhi-Meng; Wu, Jian; Popescu, Matei; Hadziyannis, Stephanos; Uludağ Üniversitesi/Tıp Fakültesi/Gastroenteroloji Anabilim Dalı.; Gürel, Selim; 7003706434
Showing results 1 to 7 of 7